Expanding ProCure’s Mission Through New Investment
September 29, 2026
ProCure On-Demand (“ProCure”), an organ recovery, logistics and technology company, today announced that DW Healthcare Partners (“DWHP”) has made a strategic investment in ProCure.
ProCure provides high-quality services that optimize organ recoveries in the US, saving transplant centers, organ procurement organizations (OPOs) and technology providers time and money. ProCure’s unique approach also ensures scientific innovation continues to advance, and education of the next generation of transplant professionals is prioritized, all with the goal of expanding the number of high-quality organs for waiting recipients.
“ProCure has shown that doing good is good business. Dr. Kon and his team have built the best-in-class solution in organ recovery and logistics. We look forward to supporting the team's future growth initiatives,” said Doug Schillinger, Managing Director with DWHP.
ProCure’s co-Founder and Chief Medical Officer, Dr. Bartley Griffith, commented, “It has been very special seeing the original idea of ProCure evolve into such an impactful organization for the transplant community. Thank you to everyone who has contributed to that evolution, including our ProCure team members, Board of Directors, Scientific and Ethical Advisory Council, as well as the customers, partners, investors and other ‘ProCure champions’ who trusted us and kept pushing us forward.”
“We wanted something very special in an investment partner,” commented Dr. Zachary Kon, ProCure’s co-Founder and CEO. “We believe DWHP’s deep experience in driving innovation and scalability to support high-growth, healthcare-focused organizations will help propel ProCure to even greater impact in the future.”
Northborne Partners served as the exclusive financial advisor to ProCure on this transaction.
About ProCure On-Demand
ProCure On-Demand is transforming the organ transplant ecosystem and enabling more thoracic and abdominal organs to reach recipients in need. ProCure provides professional, high-quality organ recovery services worthy of the first step in the transplant process. ProCure’s flexible model offers a nationwide network of recovery surgeons and clinical professionals, advanced logistics and engagement with innovative technology solutions enabling more patients to receive the transplants they need. For more information, visit www.procureodx.com.
About DW Healthcare Partners
DW Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. The firm manages six funds with over $2.7 billion in assets under management, as of December 31, 2025. DW Healthcare Partners is led by seasoned executives with more than 155 years of combined healthcare industry and investing experience. The firm provides capital, strategic guidance, and acquisition support to help mid-stage companies grow and scale. For more information, please visit: www.dwhp.com.